---
$id: https://graph.org.ai/products/commodity/51241133
$type: Product
source: UNSPSC
code: "51241133"
title: "Dorzolamide hydrochloride"
class: "51241100"
classTitle: "Ophthalmic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dorzolamide hydrochloride

**UNSPSC Code**: 51241133
**Class**: [Ophthalmic agents](Ophthalmic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a carbonic anhydrase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QZO5366EW7. European Medicines Agency schedules Dorzolamide hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01820MIG. Dorzolamide hydrochloride generally arises in the molecular formula C10H16N2O4S3.CLH. The term 'dorzolamide hydrochloride' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule dorzolamide hydrochloride under HS 29350090 and SITC 51580. As of Q4 2014, DORZOLAMIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Dorzolamide hydrochloride bears US NLM identifiers UMLS ID C0771293 and NCI Concept Code C29003. SMILES: CCN[C@H]1C[C@@H](S(=O)(=O)C2C1CC(S2)S(=O)(=O)N)C.CL.

